Daily edition
Monday 12 January
7 rounds and $657M raised. The biggest: Mirador, $250M.
Compared with Mon 5 Jan
- Rounds
- 7 +133%
- Capital raised
- $657M -67%
- Median round
- $65M ×3.3
The day in charts
Health took 49% of the capital on this day, up from <1% on Mon 5 Jan. Mirador alone raised $250M, 38% of it.
Where the capital went
Health raised $325M, 49% of the capital. Choose a sector to filter the rounds below.
| Sector | Capital | Share | Rounds |
|---|---|---|---|
| Health | $325M | 49% | 2 |
| AI | $266M | 41% | 3 |
| Other | $66M | 10% | 2 |
The 5 biggest rounds
The 5 biggest rounds raised $651M, 99% of the total.
The last two weeks
This day against the 13 days before it. The biggest: Tue 6 Jan, $20.4B.
| Day | Rounds | Capital | Biggest round |
|---|---|---|---|
| Tue 30 Dec | 0 | $0K | |
| Wed 31 Dec | 0 | $0K | |
| Thu 1 Jan | 1 | $500M | Moonshot AI, $500M |
| Fri 2 Jan | 1 | $1.8M | Moto Finance, $1.8M |
| Sat 3 Jan | 1 | $23.6M | Knight Fintech, $23.6M |
| Sun 4 Jan | 0 | $0K | |
| Mon 5 Jan | 3 | $2B | DayOne Data Centers, $2B |
| Tue 6 Jan | 9 | $20.4B | xAI, $20B |
| Wed 7 Jan | 9 | $578M | Soley Therapeutics, $200M |
| Thu 8 Jan | 6 | $986M | Cyera, $400M |
| Fri 9 Jan | 4 | $630M | Rain, $250M |
| Sat 10 Jan | 1 | $103M | Kinaset Therapeutics, $103M |
| Sun 11 Jan | 1 | $140M | Torq, $140M |
| Mon 12 Jan | 7 | $657M | Mirador, $250M |
All rounds
- MiradorDevelops clinical-stage therapies for immuno-fibrotic diseases through a multi-asset pipelineWith T. Rowe Price Investment Management, Inc., Adage Capital Partners L.P., Fidelity Management & Research Company +9 $250MSeries B
- Harmattan AIDevelops AI-based systems for defense and military applications.Led by Dassault Aviation $200MSeries B
- Inquis MedicalDevelops the AVENTUS thrombectomy system for treating blood clots in patients $75MSeries C
- AccelsiusDevelops liquid cooling systems for gigawatt-class AI data centers and factoriesLed by Johnson Controls, with Legrand $65MSeries B
- Vibrant TherapeuticsDevelops next-generation intelligent therapeutics for solid tumors, including the masked T-cell engager VIB305.With Pfizer Ventures, Apricot Capital, Bayland Capital +3 $61M
- AllosApplies Causal AI to reformulate complex small-molecule drugs for improved patient tolerability and delivery.Led by Oxford Science Enterprises, with Habico Invest, Berkeley SKYDECK $5MSeed
- EmberosProvides AI visibility services helping brands appear in AI search answers. $1.2MPre-Seed
Countries
Most active investors
More editions
Raised this day?
MediaBoost gets your round in front of the press, future hires and your next investors.
Announce your round with MediaBoost